Summit Securities Group’s Novo Nordisk NVO Stock Holding History

Summit Securities Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$6.75M	Buy
2023 Q4	–	Sell
2023 Q3	$531K	Buy
2023 Q2	$68K	Sell
2023 Q1	$1.21M	Buy
2022 Q4	$248K	Buy
2014 Q2	–	Sell
2014 Q1	$525K	Buy